Videndum
VID · Main Market · Consumer Products and Services · mcap £101m today, £91m on 23 Jul
- New CEO or CFO, 23 Jul: Appointment of Group Chief Executive Officer and Trading Update RNS
- Watch: next signal would be “Guidance cut” – “below expectations” or a profit warning, within 180 days.
AI summary with checked claims arrives with the nightly run. These lines are the matched extracts.
All announcements
-
02 Oct 26Holding(s) in CompanyRNS 9805072 ↗
-
30 Sep 26Directorate Change
In accordance with UKLR 6.4.9, the Company has been informed that Aidan de Brunner, Independent Non-Executive Director has been appointed as an Independent Non-Executive Director at Crest Nicholson Holdings plc with effect from 1 October 2026.
RNS 9798714 ↗ -
24 Sep 26Holding(s) in CompanyRNS 9789609 ↗
-
23 Sep 26Holding(s) in CompanyRNS 9787158 ↗
-
18 Sep 26Holding(s) in Company Activist stake
Videndum received the attached notice in accordance with the Disclosure and Transparency Rules from Harwood Capital LLP that it holds the following notifiable interest in the voting rights of Videndum plc.
RNS 9779912 ↗ -
25 Aug 26Director/PDMR Shareholding Director buys
Videndum plc (the "Company") announces that Jan Peter Tewes, Group Chief Executive Officer has purchased the following Ordinary shares in the Company on 24 August 2026:-
RNS 9739005 ↗ -
07 Aug 26Holding(s) in CompanyRNS 9711284 ↗
-
05 Aug 262026 Half Year Results
"Trading conditions during the first half of the year were difficult.
RNS 9704829 ↗ -
04 Aug 26Holding(s) in CompanyRNS 9704595 ↗
-
30 Jul 26Notice of HY26 Results
Videndum plc (the "Company" or the "Group") will announce its results for the half year ended 30 June 2026 ("HY26 Results") on 5 August 2026.
RNS 9695901 ↗ -
29 Jul 26Holding(s) in CompanyRNS 9694303 ↗
-
27 Jul 26Holding(s) in Company Activist stake
Videndum received the attached notice in accordance with the Disclosure and Transparency Rules from Harwood Capital LLP that it holds the following notifiable interest in the voting rights of Videndum plc.
RNS 9689477 ↗ -
23 Jul 26SIGNAL 1 New CEO or CFO
Appointment of Group Chief Executive Officer and Trading Update
Appointment of CEO and Trading Update · RNS 9683009 ↗ -
01 Jul 26Holding(s) in CompanyRNS 9648258 ↗
-
26 Jun 26
-
20 May 26Block Listing Six Monthly Return and CancellationRNS 9577707 ↗
-
19 May 26Result of AGMRNS 9576227 ↗
-
28 Apr 26Director/PDMR ShareholdingRNS 9541802 ↗
-
14 Apr 26Annual Report and Accounts 2025 & 2026 AGM Notice
Annual Report and Accounts 2025 and Notice of 2026 Annual General Meeting
RNS 9519551 ↗ -
09 Apr 26Total Voting RightsRNS 9513076 ↗
-
08 Apr 26Director/PDMR Shareholding - Correction Director buys
The following amendment has been made to the "Notification of Transactions by Directors and Persons Discharging Managerial Responsibilities (PDMRs)" announcement released on 8 April 2026 at 1:00pm under RNS No 6765Z.
RNS 9511032 ↗ -
08 Apr 26Director/PDMR Shareholding Director buys
Videndum plc (the "Company") announces that, further to the announcement of the Refinancing on 10 March 2026, in which the Directors set out an intention to participate in the Refinancing by way of a direct subscription for shares when the Company had...
RNS 9510785 ↗ -
07 Apr 26Directorate Change
Videndum plc ("Videndum" or "the Company") announces that Martin Cooke will cease to be an independent non-executive director of the Company with effect from 30 April 2026.
RNS 9508774 ↗ -
02 Apr 26Holding(s) in CompanyRNS 9505347 ↗
-
01 Apr 26Holding(s) in CompanyRNS 9504252 ↗
-
01 Apr 26Holding(s) in CompanyRNS 9504100 ↗
-
01 Apr 26Holding(s) in Company Activist stake
Videndum received the attached notice in accordance with the Disclosure and Transparency Rules from Harwood Capital LLP that it holds the following notifiable interest in the voting rights of Videndum plc.
RNS 9504059 ↗ -
01 Apr 26Holding(s) in CompanyRNS 9503377 ↗
-
01 Apr 26Holding(s) in CompanyRNS 9503372 ↗
-
31 Mar 262025 Full Year Results
"The Group made good strategic and operational progress through FY 2025.
RNS 9499203 ↗ -
27 Mar 26Results of Capital Raising and General Meeting
Further to the announcement by Videndum plc (the "Company") on 10 March 2026, the Open Offer closed for acceptances at 11.00 a.m. on 26 March 2026.
RNS 9496110 ↗ -
25 Mar 26Director Declaration
In accordance with UKLR 6.4.9(2), the Company has been informed that Graham Oldroyd, independent Non-Executive Director, has been appointed as an independent non-executive director of JPMorgan Claverhouse Investment Trust plc with effect from 7 May 2026.
RNS 9491440 ↗ -
12 Mar 26Holding(s) in CompanyRNS 9472255 ↗
-
10 Mar 26Firm Placing and Placing and Launch of Open Offer
Results of Firm Placing and Placing and Launch of Open Offer
RNS 9467549 ↗ -
10 Mar 26Publication of a ProspectusRNS 9467451 ↗
-
10 Mar 26Comprehensive Refinancing
Videndum plc ("Videndum" or the "Company", and together with its subsidiaries, the "Group") is pleased to announce the final terms of its comprehensive Refinancing, including a significant equity raise.
RNS 9465870 ↗ -
23 Dec 25Update Announcement
Videndum plc (the "Company" or the "Group") is pleased to provide an update on its ongoing negotiations with its revolving credit facility ("RCF") lenders and its two largest shareholders.
RNS 9314209 ↗ -
19 Nov 25Block listing Interim ReviewRNS 9242616 ↗
-
16 Oct 25Update announcement
Videndum plc (the "Company" or the "Group") provides an update on trading for the three months to 30 September 2025 ("Q3" or "the period") and ongoing negotiations with its RCF lenders.
RNS 9173977 ↗
Source: Investegate RNS archive. Quotes are short extracts. Not investment advice.